Sozinibercept Monoclonal Antibody
Soziniberceptis a research-grade recombinant antibody targeting Vascular endothelial growth factor C. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
UniProt
O43915, P49767
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, In vivo
Host or Source
Mammal
Preservative
0.01M PBS, pH 7.4.
Isotype
Vascular Endothelial Growth Factor Receptor 3 fusion protein with IgG1 Fc Fragment.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
K0746, NT (SEL1L3, KIAA0746, Protein sel-1 homolog 3, Suppressor of lin-12-like protein 3) (AP)
K0746, NT (SEL1L3, KIAA0746, Protein sel-1 homolog 3, Suppressor of lin-12-like protein 3) (AP)
Cyp4f17 CRISPRa sgRNA lentivector (set of three targets)(Rat)
Recombinant Cryptomeria japonica Photosystem II D2 protein (psbD), partial
Bcl-2, Phosphorylated (T56) (BCL2, Apoptosis regulator Bcl-2) (Biotin)